ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 126 filers reported holding ACCELERON PHARMA INC in Q4 2015. The put-call ratio across all filers is 2.00 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $4,743,000 | +21.1% | 26,750 | -15.7% | 0.01% | +18.2% |
Q2 2021 | $3,916,000 | +24.2% | 31,750 | +33.7% | 0.01% | +10.0% |
Q1 2021 | $3,154,000 | +5.8% | 23,750 | 0.0% | 0.01% | -9.1% |
Q4 2020 | $2,980,000 | -1.3% | 23,750 | -11.9% | 0.01% | -15.4% |
Q3 2020 | $3,018,000 | -70.1% | 26,950 | -89.2% | 0.01% | -79.4% |
Q3 2019 | $10,087,000 | -27.7% | 249,484 | -26.8% | 0.06% | -10.0% |
Q2 2019 | $13,949,000 | -11.4% | 340,884 | +16.6% | 0.07% | -25.5% |
Q1 2019 | $15,742,000 | +71.3% | 292,230 | +35.6% | 0.09% | +54.1% |
Q4 2018 | $9,188,000 | -41.6% | 215,530 | -26.2% | 0.06% | -34.4% |
Q3 2018 | $15,742,000 | +48.3% | 292,230 | -6.4% | 0.09% | +34.8% |
Q2 2018 | $10,613,000 | -12.5% | 312,330 | +1.6% | 0.07% | -16.9% |
Q1 2018 | $12,133,000 | +1743.9% | 307,330 | +1526.1% | 0.08% | +1560.0% |
Q4 2017 | $658,000 | 0.0% | 18,900 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $658,000 | +12.9% | 18,900 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $583,000 | +15.4% | 18,900 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $505,000 | -4.0% | 18,900 | -7.4% | 0.01% | -16.7% |
Q4 2016 | $526,000 | -23.5% | 20,400 | +7.9% | 0.01% | -25.0% |
Q3 2016 | $688,000 | +4.1% | 18,900 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $661,000 | +61.6% | 18,900 | +18.9% | 0.01% | +60.0% |
Q1 2016 | $409,000 | -50.9% | 15,900 | -5.4% | 0.01% | -50.0% |
Q4 2015 | $833,000 | +102.7% | 16,800 | +1.8% | 0.01% | +100.0% |
Q3 2015 | $411,000 | -17.3% | 16,500 | +5.1% | 0.01% | -16.7% |
Q2 2015 | $497,000 | -13.6% | 15,700 | +4.0% | 0.01% | -14.3% |
Q1 2015 | $575,000 | – | 15,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |